EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Integrating Fetuin-A and Lipid-Based Phenotyping as Markers of Cardiometabolic Risk in Subclinical Hypothyroidism

Al Anoud N Abdallah, Ola M Al-Sanabra

Medical Principles and Practice · 09.07.2026 · 1-11

DOI: 10.1159/000553492 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Principles and Practice, online erschienen am 09.07.2026. Verfasst von Al Anoud N Abdallah und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Sciences, Faculty of Allied Medical Sciences, Al-Balqa Applied University, Salt, Jordan. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The aims of the study were to evaluate fetuin-A (FA) as an integrative biomarker for cardiometabolic risk in subclinical hypothyroidism (SCH) and to investigate lipid-based metabolic heterogeneity. Subject and Methods: In this cross-sectional study, 192 participants (105 SCH, 87 controls) were evaluated for thyroid function, metabolic parameters, lipid profiles, FA, and high-sensitivity C-reactive protein (hs-CRP). Lipid phenotyping was performed using principal component analysis (PCA) and latent profile analysis (LPA). A composite cardiovascular disease risk index (CVDRI) incorporating FA and the atherogenic index of plasma (AIP) was calculated. Correlation, regression, and receiver operating characteristic (ROC) analysis were conducted.

Results

SCH patients exhibited significantly elevated thyroid-stimulating hormone (TSH), insulin resistance, dyslipidemia, hs-CRP, and FA compared to controls (p < 0.0001). FA showed strong correlations with TSH, lipid parameters, insulin resistance, and CVDRI (ρ = 0.60–0.77, p < 0.001). PCA and LPA identified three distinct SCH phenotypes, each showing progressively adverse metabolic and inflammatory profiles. ROC analysis showed excellent discriminatory performance for FA and CVDRI (AUCs >95%), whereas lipid-derived indices distinguished high-risk phenotypes.

Conclusion

FA is a promising integrative biomarker linking thyroid dysfunction with cardiometabolic risk in SCH. Lipid-based phenotyping highlights disease heterogeneity and supports the use of composite biomarker strategies for early risk stratification and personalized management.

Schlagwörter

Stichwörter der Autor:innen

Cardiometabolic riskFetuin-ALatent profile analysisLipid profilingSubclinical hypothyroidism

Autor:innen und Institutionen

  • Department of Medical Laboratory Sciences, Faculty of Allied Medical Sciences, Al-Balqa Applied University, Salt, Jordan.
  • Department of Medical Laboratory Sciences, Faculty of Allied Medical Sciences, Al-Balqa Applied University, Salt, Jordan, ola.sanabra@bau.edu.jo.

Zitieren

APA

Abdallah, A. A. N., & Al-Sanabra, O. M. (2026). Integrating Fetuin-A and Lipid-Based Phenotyping as Markers of Cardiometabolic Risk in Subclinical Hypothyroidism. Medical Principles and Practice, 1-11. https://doi.org/10.1159/000553492

Vancouver

Abdallah AAN, Al-Sanabra OM. Integrating Fetuin-A and Lipid-Based Phenotyping as Markers of Cardiometabolic Risk in Subclinical Hypothyroidism. Medical Principles and Practice. 2026:1-11. doi:10.1159/000553492

BibTeX
@article{Abdallah2026,
  author = {Abdallah, Al Anoud N and Al-Sanabra, Ola M},
  title = {Integrating Fetuin-A and Lipid-Based Phenotyping as Markers of Cardiometabolic Risk in Subclinical Hypothyroidism},
  journal = {Medical Principles and Practice},
  year = {2026},
  pages = {1--11},
  doi = {10.1159/000553492}
}
Kostenlos starten →